Discovery, Synthesis, and Biological Evaluation of Anaenamides C and D from a New Marine Cyanobacterium, Hormoscilla sp.

David A. Brumley,Sarath P. Gunasekera,Thomas Sauvage,Larissa A. H. dos Santos,Qi-Yin Chen,Valerie J. Paul,Hendrik Luesch

DOI: https://doi.org/10.1021/acs.jnatprod.1c01073

IF: 5.1

2022-02-15

Journal of Natural Products

Abstract:Our ongoing efforts to explore the chemical space associated with marine cyanobacteria from coral reefs of Guam have yielded two new members of the anaenamide family of natural products, anaenamides C (3) and D (4). These compounds were isolated from a novel Hormoscilla sp. (VPG16-58). Our phylogenetic profiling (16S rDNA) of this cyanobacterium indicated that VPG16-58 is taxonomically distinct from the previously reported producer of the anaephenes, VPG16-59 (Hormoscilla sp.), and other previously documented species of the genus Hormoscilla. The planar structures of 3 and 4 were determined via spectroscopic methods, and absolute configurations of the α-hydroxy acids were assigned by enantioselective HPLC analysis. To address the requirement for sufficient material for testing, we first adapted our published linear synthetic approach for 1 and 2 to generate anaenoic acid (7), which served as a point for diversification, providing the primary amides 3 and 4 from synthetic intermediates 5 and 6, respectively. The compounds were then tested for effects on HCT116 colon cancer cell viability and in an ARE-luciferase reporter gene assay for Nrf2 modulation using HEK293 human embryonic kidney cells. Our findings indicate that, in contrast to cytotoxic methyl esters 1 and 2, the primary amides 3 and 4 activate the Nrf2 pathway at noncytotoxic concentrations. Overall, our data suggest that the anaenamide scaffold is tunable to produce differential biological outcomes.

plant sciences,chemistry, medicinal,pharmacology & pharmacy

What problem does this paper attempt to address?

The paper aims to address the following issues: 1. **Discovery of New Compounds**: Two new members of the anaenamide family, anaenamide C (3) and anaenamide D (4), were discovered from an undescribed cyanobacterium (Hormoscilla sp.) from the coral reefs of Guam. 2. **Structure Determination and Synthesis**: The planar structures of these compounds were determined by spectroscopic methods, and the absolute configuration of the α-hydroxy acid was determined by chiral HPLC analysis. Additionally, the paper reports how these compounds were generated from synthetic intermediates through a linear synthesis method. 3. **Biological Activity Evaluation**: The effects of these compounds on the viability of HCT116 colon cancer cells and the Nrf2 regulatory activity in HEK293 human embryonic kidney cells were studied. The results indicate that, compared to previously reported cytotoxic methyl ester compounds, these new primary amide compounds can activate the Nrf2 pathway at non-cytotoxic concentrations. Overall, the paper demonstrates that by adjusting the nature of the Michael acceptor, different biological activities can be isolated, thereby achieving different pharmacological effects.

Discovery, Synthesis, and Biological Evaluation of Anaenamides C and D from a New Marine Cyanobacterium, Hormoscilla sp.

Synthesis and Biological Evaluation of Analogues of the Marine Cyclic Depsipeptide Obyanamide.

Ammonificins C and D, Hydroxyethylamine Chromene Derivatives from a Cultured Marine Hydrothermal Vent Bacterium, Thermovibrio ammonificans

Hormaomycins B and C: New Antibiotic Cyclic Depsipeptides from a Marine Mudflat-Derived Streptomyces sp.

Structure and Biosynthesis of Hectoramide B, a Linear Depsipeptide from Marine Cyanobacterium Moorena producens JHB Discovered via Coculture with Candida albicans

Exploration on natural product anibamine side chain modification toward development of novel CCR5 antagonists and potential anti-prostate cancer agents

Targeted Discovery of Amantamide B, an Ion Channel Modulating Nonapeptide from a South China Sea Oscillatoria Cyanobacterium

Two new amides from a halotolerant fungus, Myrothecium sp. GS-17

Albusamides A-G: Hydroxylated Fatty Amine Derivatives from the Deep-Sea-Derived Actinomycete Streptomyces albus 228DD-066 and Their Cytotoxic Activity

New bioactive compounds from the marine-derived actinomycete Nocardiopsis lucentensis sp. ASMR2

A New Dihydrochromone Dimer and Other Secondary Metabolites from Cultures of the Marine Sponge-Associated Fungi Neosartorya fennelliae KUFA 0811 and Neosartorya tsunodae KUFC 9213

Chemical synthesis, in vitro testing and in silico Nampt-based molecular docking of novel aniline aromatic ring-substituted 2-Aminothiazole analogues

Sclerotiamides C-H, Notoamides from a Marine Gorgonian-Derived Fungus with Cytotoxic Activities.

Discovery of a Novel Chromone Enantiomer and the Precursors of Nonactic Acid from the Coral-Reef-Derived Streptomyces sp. SCSIO 66814

Cellulamides: A New Family of Marine-Sourced Linear Peptides from the Underexplored Cellulosimicrobium Genus

Antiproliferative in Vitro Evaluation of Terpenic Amines Synthesized via a Rhodium‐catalyzed Hydroaminomethylation

Identification of the Biosynthetic Gene Cluster of Thermoactinoamides and Discovery of New Congeners by Integrated Genome Mining and MS-Based Molecular Networking

Chlorinated bis-indole alkaloids from deep-sea derived Streptomyces sp. SCSIO 11791 with antibacterial and cytotoxic activities

Metabolomic Characterization of a cf. Neolyngbya Cyanobacterium from the South China Sea Reveals Wenchangamide A, a Lipopeptide with In Vitro Apoptotic Potential in Colon Cancer Cells

Solid-phase total synthesis of cherimolacyclopeptide E and discovery of more potent analogues by alanine screening

Antiprotozoal Activity Against Entamoeba hystolitica and Giardia lamblia of Cyclopeptides Isolated from Annona diversifolia Saff